A novel ERBB4 agonist attenuates cardiac remodelling after myocardial infarction in a sex-specific manner

14 May 2024 (09:45 - 09:53)
Organised by: Logo
Congress Presentation Part of: Tailoring heart failure therapies on patient profiles Pharmacotherapy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by